Human Immunodeficiency Virus Proteinase
Human Immunodeficiency Virus Proteinase
批准号:
6751294
负责人:
Ben M. Dunn
金额:
$28.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 2005-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by applicant): Antiretroviral therapy with a combination
of RT and PR inhibitors has had a profound effect upon the management of HIV-1
infection. However, under drug pressure, the virus is able to evolve into forms
that are resistant to the available drug regimens. Thus, drug resistance has
become the most significant challenge to AIDS therapy. We have been studying a
pediatric population undergoing a clinical trial with protease inhibitors in
combination with RT inhibitors. We have discovered that evolution of the
protease sequence is accompanied by evolution of the sequence of the cleavage
sites within Gag/Pol, thus affecting the efficiency of processing. Furthermore,
the evolution of protease is accompanied by alterations in cleavage
specificity. We hypothesize that the Gag/Pol cleavage sites and PR form a
functional unit in which sequence evolution may be co- dependent. In our
renewal period, we will exploit these discoveries to gain additional
understanding of the mechanisms of Gag/Pol processing. To this end, we will
pursue the following specific aims: Specific Aim I will analyze natural Gag/Pol
alleles for processing phenotype in a bacterial expression developed in the
current period of support. We will also map the determinants by preparation of
chimeric gag/pol constructs and analyze replication of recombinant virus with
natural or chimeric gag/pol regions. Specific Aim 2 will study the growth of
recombinant virus in the presence of anti-protease drugs in culture. In
addition, new protease alleles will be subcloned and expressed for analysis by
studies of substrate specificity using a combinatorial library of substrates,
and by analysis of the binding of inhibitors. Specific Aim 3 will study the
effects of changes in the sequence of Gag processing sites on the efficiency of
processing. We will prepare peptides representing products of Gag/Pol
processing and test their ability to inhibit the enzyme. We will also conduct
structural analyses of fusions of Gag/Pol proteins with an inactive form of HIV
PR in order to determine the role of structural organization in the processing
events.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Anatomy and pathology of HIV-1 peptidase.
HIV-1 肽酶的解剖学和病理学。
DOI:
10.1042/bse0380113
发表时间:
2002
期刊:
Essays in biochemistry
影响因子:
6.4
作者:
[Dunn,BenM]
通讯作者:
Dunn,BenM
DOI:
10.1016/s0167-4838(96)00224-5
发表时间:
1997-04
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[S. Wilson;L. H. Phylip;J. Mills;S. Gulnik;J. Erickson;B. Dunn;J. Kay]
通讯作者:
S. Wilson;L. H. Phylip;J. Mills;S. Gulnik;J. Erickson;B. Dunn;J. Kay
Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases.
底物和抑制剂与束缚的 HIV-1 和 HIV-2 同二聚体和异二聚体蛋白酶家族的相互作用。
DOI:
--
发表时间:
1994
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Griffiths,JT, Tomchak,LA, Mills,JS, Graves,MC, Cook,ND, Dunn,BM, Kay,J]
通讯作者:
Kay,J
A comparison of gag-pol precursor cleavage in naturally arising HIV variants.
自然产生的 HIV 变体中 gag-pol 前体裂解的比较。
DOI:
10.1007/978-1-4615-5373-1_7
发表时间:
1998
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Bloom,G, Perez,E, Parikh,S, Kay,J, Mills,J, Goodenow,M, Dunn,BM]
通讯作者:
Dunn,BM
Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem.
抑制剂与猫科动物和人类免疫缺陷病毒蛋白酶结合的比较:基于结构的药物设计和耐药性问题。
DOI:
10.1002/(sici)1097-0282(1999)51:1
发表时间:
1999
期刊:
Biopolymers.
影响因子:
--
作者:
[Dunn,BM, Pennington,MW, Frase,DC, Nash,K]
通讯作者:
Nash,K
共 19 条
Human Immunodeficiency Virus Proteinase
-
批准号:7846703
-
项目类别:
-
资助金额:$8.97万
-
财政年份:2009
-
负责人:Ben M. Dunn
-
依托单位:
NOVEL INHIBITORS OF FUNGAL ASPARTIC PROTEINASES
-
批准号:6626411
-
项目类别:
-
资助金额:$21.4万
-
财政年份:2001
-
负责人:Ben M. Dunn
-
依托单位:
NOVEL INHIBITORS OF FUNGAL ASPARTIC PROTEINASES
-
批准号:6312013
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2001
-
负责人:Ben M. Dunn
-
依托单位:
NOVEL INHIBITORS OF FUNGAL ASPARTIC PROTEINASES
-
批准号:6488787
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2001
-
负责人:Ben M. Dunn
-
依托单位:
HEPATITIS C VIRUS NS3 PROTEASE--ACTIVE SITE
-
批准号:2330570
-
项目类别:
-
资助金额:$28.0万
-
财政年份:1996
-
负责人:Ben M. Dunn
-
依托单位:
PROTEOLYTIC ENZYMES AND THEIR INHIBITORS
-
批准号:2190100
-
项目类别:
-
资助金额:$0.3万
-
财政年份:1994
-
负责人:Ben M. Dunn
-
依托单位:
PICORNAVIRAL PROCESSING PROTEINASES
-
批准号:3547945
-
项目类别:
-
资助金额:$20.44万
-
财政年份:1991
-
负责人:Ben M. Dunn
-
依托单位:
PICORNAVIRAL PROCESSING PROTEINASES
-
批准号:3547944
-
项目类别:
-
资助金额:$19.72万
-
财政年份:1991
-
负责人:Ben M. Dunn
-
依托单位:
PICORNAVIRAL PROCESSING PROTEINASES
-
批准号:2066857
-
项目类别:
-
资助金额:$20.78万
-
财政年份:1991
-
负责人:Ben M. Dunn
-
依托单位:
PICORNAVIRAL PROCESSING PROTEINASES
-
批准号:3547943
-
项目类别:
-
资助金额:$23.15万
-
财政年份:1991
-
负责人:Ben M. Dunn
-
依托单位:
Human Immunodeficiency Virus Proteinase
-
批准号:6510426
-
项目类别:
-
资助金额:$27.22万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE
-
批准号:2886621
-
项目类别:
-
资助金额:$21.21万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
Human Immunodeficiency Virus Proteinase
-
批准号:8427357
-
项目类别:
-
资助金额:$38.4万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
Human Immunodeficiency Virus Proteinase
-
批准号:7676271
-
项目类别:
-
资助金额:$40.88万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE
-
批准号:2671966
-
项目类别:
-
资助金额:$20.59万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE
-
批准号:2064547
-
项目类别:
-
资助金额:$17.32万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE
-
批准号:2330348
-
项目类别:
-
资助金额:$19.99万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE
-
批准号:6169958
-
项目类别:
-
资助金额:$21.84万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
Human Immunodeficiency Virus Proteinase
-
批准号:7384472
-
项目类别:
-
资助金额:$35.74万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE
-
批准号:3143158
-
项目类别:
-
资助金额:$17.3万
-
财政年份:1989
-
负责人:Ben M. Dunn
-
依托单位:
海外基金